|1.||Martinelli, Giovanni: 1 article (07/2013)|
|2.||Pogliani, Enrico: 1 article (07/2013)|
|3.||Castagnola, Carlo: 1 article (07/2013)|
|4.||Rodeghiero, Francesco: 1 article (07/2013)|
|5.||Morra, Enrica: 1 article (07/2013)|
|6.||Beghini, Alessandro: 1 article (07/2013)|
|7.||Ferrara, Felicetto: 1 article (07/2013)|
|8.||Pizzolo, Giovanni: 1 article (07/2013)|
|9.||Rossi, Giuseppe: 1 article (07/2013)|
|10.||Lazzaroni, Francesca: 1 article (07/2013)|
|1.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/01/2013 - "Acute myeloid leukemia (AML) with deranged core-binding factor beta (CBFβ) is usually associated with a favorable prognosis with 50-70% of patients cured using contemporary treatments. "
07/01/2013 - "Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta."
12/01/2006 - "The gene encoding for core-binding factor beta (CBFbeta) is altered in acute myeloid leukemia samples with an inversion in chromosome 16, expressing the fusion protein CBFbeta-SMMHC. "
02/01/2003 - "Evidence from these models supports the idea that acute myeloid leukemia 1/core-binding factor beta-subunit (AML1/CBFbeta) has a critical role in the control of the self-renewal capacity of hematopoietic stem cells and their progeny. "
08/01/2002 - "The core binding factor beta (CBFbeta) gene located on 16q22 is known to be frequently involved in acute myelocytic leukemia. "
09/13/2002 - "The genes for RUNX1, also termed acute myeloid leukemia protein 1, AML1, and its dimerization partner core-binding factor beta, CBFbeta, are essential for hematopoietic development and are together the most common targets for gene rearrangements in acute human leukemias. "
04/15/2002 - "Acceleration of G(1) cooperates with core binding factor beta-smooth muscle myosin heavy chain to induce acute leukemia in mice."
06/01/2011 - "Acute myelomonocytic leukemia with eosinophilia is commonly associated with pericentric inversions of chromosome 16, involving the core binding factor beta gene (CBFB) on 16q22 and the myosin heavy chain gene (MYH11) on 16p13. "
04/15/2007 - "Inversion of chromosome 16, inv(16)(p13q22), juxtaposes the core binding factor beta (CBFB) and myosin heavy chain 11 (MYH11) genes, resulting in a myeloid leukemic disease phenotype characterized by increased bone marrow and peripheral blood blasts with myelomonocytic antigen expression and an accompanying eosinophilia. "
|4.||Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/15/2005 - "Detectable by fluorescence in situ hybridization (FISH), these losses of sequence include deletion of the 5' region of the ABL gene and the 3' region of BCR in chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), as well as the 5' region of ETO in acute myeloid leukemia (AML) French-American-British type M2 associated with t(8;21), 3'MLL in AML and ALL, and 3' core-binding factor beta (CBFbeta) in AML associated with inv(16). "
|5.||Acute Myelomonocytic Leukemia
|1.||Myosin Heavy Chains (Myosin Heavy Chain)
|2.||Transcription Factors (Transcription Factor)
|3.||Carrier Proteins (Binding Protein)
|5.||Core Binding Factors (Core-Binding Factor)
|6.||Nuclear Localization Signals (Nuclear Localization Signal)
|9.||Proteins (Proteins, Gene)